The Reliability and Validity of Turkish Version of ''The Dyspnea-ALS-Scale (DALS-15)"

The Dyspnea-ALS-Scale (DALS-15) is a uni-dimensional scale to measure dyspnea in patients with Amyotrophic Lateral Sclerosis. It can be easily and rapidly applied. The aim of this study is to investigate reliability and validity of Turkish version of the DALS-15.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Amyotrophic Lateral Sclerosis Central Nervous System Diseases Dyspnea Metabolic Diseases Motor Neuron Disease Nervous System Diseases Neurodegenerative Diseases Neuromuscular Diseases Nutritional and Metabolic Diseases Pathological Conditions, Signs and Symptoms Proteostasis Deficiencies Respiration Disorders Respiratory Tract Diseases Signs and Symptoms Signs and Symptoms, Respiratory Spinal Cord Diseases TDP-43 Proteinopathies

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Istanbul Faculty of Medicine

Istanbul, 34700, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age of 18 or above
Dyspnea on exertion, dyspnea at rest, or orthopnea without evidence of pulmonary or cardiac causes of dyspnea

Exclusion criteria

Severe cognitive dysfunction

Treatment and study plan

Primary outcomes

The Dyspnea-ALS-Scale (DALS-15)

Time frame: 10 minutes

The scale is used to measure dyspnea in ALS patients

Secondary outcomes

Modified Borg Scale

Time frame: 10 minutes

A 10 point Modified Borg Scale is used to assess dyspnea in supine and standing positions.
Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R)

Time frame: 15 minutes

It is used to assess functional stats in ALS patients. This study particularly focus on pulmonary functions and dyspnea subscale of the scale.

Sponsors and collaborators

Lead sponsor

Istanbul Medeniyet University

Other

Collaborators

Istanbul University
Istanbul University - Cerrahpasa

Registry information

Important dates

Study start: 2020
Primary completion: 2021
Study completion: 2021
First posted: Mar 12, 2020
Registry last updated: Apr 9, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting